|
1
|
Jemal A, Center MM, DeSantis C and Ward
EM: Global patterns of cancer incidence and mortality rates and
trends. Cancer Epidemiol Biomarkers Prev. 19:1893–1907. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yu JL, Simmons C, Victor JC, Han D,
Hogeveen S, Leighl N and Verma S: Impact of new chemotherapeutic
and targeted agents on survival in stage IV non-small cell lung
cancer. Oncologist. 16:1307–1315. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Du L, Borkowski R, Zhao Z, Ma X, Yu X, Xie
XJ and Pertsemlidis A: A high-throughput screen identifies miRNA
inhibitors regulating lung cancer cell survival and response to
paclitaxel. RNA Biol. 10:1700–1713. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guo HL, Ingolia NT, Weissman JS and Bartel
DP: Mammalian microRNAs predominantly act to decrease target mRNA
levels. Nature. 466:835–840. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen QJ, Chen XB, Zhang MZ, Fan QX, Luo SX
and Cao XG: miR-137 is frequently down-regulated in gastric cancer
and is a negative regulator of Cdc42. Dig Dis Sci. 56:2009–2016.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao YY, Li YP, Lou GY, Zhao L, Xu Z,
Zhang Y and He F: MiR-137 targets estrogen-related receptor alpha
and impairs the proliferative and migratory capacity of breast
cancer cells. PLoS One. 7:e391022012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bi Y, Han Y, Bi H, Gao F and Wang X:
miR-137 impairs the proliferative and migratory capacity of human
non-small cell lung cancer cells by targeting paxillin. Hum Cell.
27:95–102. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhu X, Li Y, Shen H, Li H, Long L, Hui L
and Xu W: miR-137 inhibits the proliferation of lung cancer cells
by targeting Cdc42 and Cdk6. FEBS Lett. 587:73–81. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dacic S, Kelly L, Shuai Y and Nikiforova
MN: miRNA expression profiling of lung adenocarcinomas: Correlation
with mutational status. Mod pathol. 23:1577–1582. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ciafrè SA, Galardi S, Mangiola A, Ferracin
M, Liu CG, Sabatino G, Negrini M, Maira G, Croce CM and Farace MG:
Extensive modulation of a set of microRNAs in primary glioblastoma.
Biochem Biophys Res Commun. 334:1351–1358. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bandrés E, Cubedo E, Agirre X, Malumbres
R, Zárate R, Ramirez N, Abajo A, Navarro A, Moreno I, Monzó M and
García-Foncillas J: Identification by Real-time PCR of 13 mature
microRNAs differentially expressed in colorectal cancer and
non-tumoral tissues. Mol Cancer. 5:292006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Svoboda M, Izakovicova Holla L, Sefr R,
Vrtkova I, Kocakova I, Tichy B and Dvorak J: Micro-RNAs miR125b and
miR137 are frequently upregulated in response to capecitabine
chemoradiotherapy of rectal cancer. Int J Oncol. 33:541–547.
2008.PubMed/NCBI
|
|
15
|
Zhang B, Liu T, Wu T, Wang Z, Rao Z and
Gao J: microRNA-137 functions as a tumor suppressor in human
non-small cell lung cancer by targeting SLC22A18. Int J Biol
Macromol. 74:111–118. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li P, Ma L, Zhang Y, Ji F and Jin F:
MicroRNA-137 down-regulates KIT and inhibits small cell lung cancer
cell proliferation. Biomed Pharmacother. 68:7–12. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shi H, Ji Y, Zhang D, Liu Y and Fang P:
MiR-135a inhibits migration and invasion and regulates EMT-related
marker genes by targeting KLF8 in lung cancer cells. Biochem
Biophys Res Commun. 465:125–130. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhen Q, Liu J, Gao L, Liu J, Wang R, Chu
W, Zhang Y, Tan G, Zhao X and Lv B: MicroRNA-200a targets EGFR and
c-Met to inhibit migration, invasion and gefitinib resistance in
non-small cell lung cancer. Cytogenet Genome Res. 146:1–8. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hossain A, Kuo MT and Saunders GF:
Mir-17-5p regulates breast cancer cell proliferation by inhibiting
translation of AIB1 mRNA. Mol Cell Biol. 26:8191–8201. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu J and OMalley BW: Molecular mechanisms
and cellular biology of the steroid receptor coactivator (SRC)
family in steroid receptor function. Rev Endocr Metab Disord.
3:185–192. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Anzick SL, Kononen J, Walker RL, Azorsa
DO, Tanner MM, Guan XY, Sauter G, Kallioniemi OP, Trent JM and
Meltzer PS: AIB1, a steroid receptor coactivator amplified in
breast and ovarian cancer. Science. 277:965–968. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Waters CE, Stevens A, White A and Ray DW:
Analysis of co-factor function in a glucocorticoid-resistant small
cell carcinoma cell line. J Endocrinol. 183:375–383. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Henke RT, Haddad BR, Kim SE, Rone JD, Mani
A, Jessup JM, Wellstein A, Maitra A and Riegel AT: Overexpression
of the nuclear receptor coactivator AIB1, (SRC-3) during
progression of pancreatic adenocarcinoma. Clin Cancer Res.
10:6134–6142. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Suen CS, Berrodin TJ, Mastroeni R, Cheskis
BJ, Lyttle CR and Frail DE: A transcriptional coactivator, steroid
receptor coactivator-3, selectively augments steroid receptor
transcriptional activity. J Biol Chem. 273:27645–27653. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang H, Zhang D, Wu W, Zhang J, Guo D,
Wang Q, Jing T, Xu C, Bian X and Yang K: Overexpression and
gender-specific differences of SRC-3 (SRC-3/AIB1) immunoreactivity
in human non-small cell lung cancer: an in vivo study. J Histochem
Cytochem. 58:1121–1127. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jiang HL, Yu H, Ma X, Xu D, Lin GF, Ma DY
and Jin JZ: MicroRNA-195 regulates steroid receptor coactivator-3
protein expression in hepatocellular carcinoma cells. Tumour Biol.
35:6955–6960. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Silber J, Lim DA, Petritsch C, Persson AI,
Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello
JF, et al: miR-124 and miR-137 inhibit proliferation of
glioblastoma multiforme cells and induce differentiation of brain
tumor stem cells. Bmc Med. 6:142008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Balaguer F, Link A, Lozano JJ, Cuatrecasas
M, Nagasaka T, Boland CR and Goel A: Epigenetic Silencing of
miR-137 is an early event in colorectal carcinogenesis. Cancer Res.
70:6609–6618. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang T, Jiang M, Kong XY and Cai YD:
Dysfunctions associated with methylation, microRNA expression and
gene expression in lung cancer. PLoS One. 7:e434412012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shiomi N, Mori M, Tsuji H, Imai T, Inoue
H, Tateishi S, Yamaizumi M and Shiomi T: Human RAD18 is involved in
S phase-specific single-strand break repair without PCNA
monoubiquitination. Nucleic Acids Res. 35:e92007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Deng J, He M, Chen L, Chen C, Zheng J and
Cai Z: The loss of miR-26a-mediated post-transcriptional regulation
of cyclin E2 in pancreatic cancer cell proliferation and decreased
patient survival. PLoS One. 8:e764502013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cheung TH and Rando TA: Molecular
regulation of stem cell quiescence. Nat Rev Mol Cell Bio.
14:329–340. 2013. View
Article : Google Scholar
|
|
33
|
Levkau B, Koyama H, Raines EW, Clurman BE,
Herren B, Orth K, Roberts JM and Ross R: Cleavage of p21
(Cip1/Waf1) and p27 (Kip1) mediates apoptosis in endothelial cells
through activation of Cdk2: Role of a caspase cascade. Mol Cell.
1:553–563. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jun GJ, Zhong GG and Ming ZS: miR-218
inhibits the proliferation of glioma U87 cells through the
inactivation of the CDK6/cyclin D1/p21(Cip1/Waf1) pathway. Oncol
Lett. 9:2743–2749. 2015.PubMed/NCBI
|
|
35
|
Deng Y, Deng H, Bi F, Liu J, Bemis LT,
Norris D, Wang XJ and Zhang Q: MicroRNA-137 targets
carboxyl-terminal binding protein 1 in melanoma cell lines. Int J
Biol Sci. 7:133–137. 2011. View Article : Google Scholar : PubMed/NCBI
|
